Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

COVID-19 control measures reduce walking activities in United States

An international team of researchers has conducted a study demonstrating the effects that coronavirus disease 2019 (COVID-19) control measures have had on people’s walking patterns in the United States.

9 Dec 2020

Study suggests vast majority of Seattle population remains susceptible to COVID-19

Researchers in the United States have conducted a study suggesting that a small proportion of people living in Seattle were infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – by around late March/early April 2020.

9 Dec 2020

Different SARS-CoV-2 neutralization assays are reliable and concordant for antibody monitoring

A recent study by US researchers, currently available on the medRxiv preprint server, evaluated several cell-based assays that are under validation for determining correlates of protection in individuals with symptomatic coronavirus disease (COVID-19) and vaccine studies – and demonstrated their high concordance with both live and pseudotyped virions.

9 Dec 2020

The impact of COVID-19 on emergency medical services: a case study

A team of researchers based in Turkey has now studied the pandemic's effect on emergency medical services (EMS). Their study, titled "Effects of COVID‐19 pandemic on emergency medical services," was published in the latest issue of The International Journal of Clinical Practice.

9 Dec 2020

Obesity increases the risk of severe COVID-19, study finds

Researchers reveal that being overweight and obese are common risk factors for developing severe COVID-19. However, they suggested further assessment of metabolic parameters, including body mass index (BMI), waist-hip ratio, and insulin levels, to estimate the risk.

9 Dec 2020

Researchers develop analytical model to gauge SARS-CoV-2 transmission dynamics in schools

Research highlight the risk of virus spread in schools in the Netherlands. Since most schools across countries have resumed in-person or face-to-face classes, knowing the virus's risk and transmission dynamics in this context is crucial.

9 Dec 2020

The effects of cigarette smoke and COPD on SARS-CoV-2 infection

Researchers have revealed some of the effects of cigarette smoke and chronic obstructive pulmonary disease (COPD) on SARS-CoV-2 infection.

9 Dec 2020

UofL receives DoD funding to develop a nasal spray for preventing COVID-19

The University of Louisville has received funding from the U.S. Department of Defense (DoD) to develop a nasal spray to prevent serious viral respiratory infections such as COVID-19 using Q-Griffithsin, a drug compound developed and co-owned by UofL.

9 Dec 2020

What safety measures have food suppliers implemented in response to COVID-19?

Researchers surveyed small to large food companies in 16 countries on food safety attributes and emergency plans. They found that less than half the food companies had documented putting emergency plans in place for pandemics and public health crises.

9 Dec 2020

Neutrophils may play a key role in COVID-19-related thrombosis

A team of researchers in Italy have published a study suggesting that rather than platelets, neutrophils could be playing the lead role in thrombotic complications associated with COVID-19.

9 Dec 2020

Considerable COVID-19 vaccination hesitancy in UK may affect herd immunity, study finds

Scientists from the Imperial College London and the Imperial College Healthcare NHS Trust, UK, have conducted a cross-sectional, questionnaire-based survey to evaluate the public’s willingness to receive coronavirus disease 2019 (COVID-19) vaccination and their attitude toward prioritization.

9 Dec 2020

Predicting SARS-CoV-2 protein sequences

SARS-CoV-2, the causative agent of COVID-19, consists of an assembly of proteins that determine its infectious and immunological behavior.

9 Dec 2020

Developing antimicrobial products with resistance to coronavirus

In this interview, News-Medical spoke to Charles Churchman, Co-founder of Veraco, about their antimicrobial products that have been designed to have resistance to coronavirus.

9 Dec 2020

Interim results show Oxford COVID-19 vaccine protects against symptomatic disease

First full results from interim analysis confirm that the Oxford COVID-19 vaccine (AZD1222) has an acceptable safety profile and is efficacious against symptomatic COVID-19 disease, with no hospitalizations or severe disease reported in the COVID-19 vaccine group so far.

9 Dec 2020

Researchers compare data from blood donors to infer the attack rate of SARS-CoV-2 virus

Researchers studying data from blood donors in Manaus, Brazil, who experienced high mortality from SARS-CoV-2, estimate that more than 70% of the population was infected approximately seven months after the virus first arrived in the city.

9 Dec 2020

Scientists determine key molecular processes used by coronavirus to infect human cells

When a coronavirus--including SARS-CoV-2, which causes COVID-19--infects someone, it hijacks the person's cells, co-opting their molecular machinery for its own survival and spread.

9 Dec 2020

Researchers assess the binding behavior of SARS-CoV-2 virus

The binding of a SARS-CoV-2 virus surface protein spike -- a projection from the spherical virus particle -- to the human cell surface protein ACE2 is the first step to infection that may lead to COVID-19 disease.

8 Dec 2020

Amilorides reduce SARS-CoV-2 viral replication in vitro

A new U.S. study published on the bioRxiv preprint server reports the use of an amiloride-based scaffold that targets a viral RNA structure known to be essential in viral replication in the 5’-untranslated region (UTR) of the virus. The researchers say this heralds the application of these molecules as chemical probes to explore viral biology and produce specific antivirals targeting RNA regions of the coronavirus genome.

8 Dec 2020

UC Davis Health joins with Novavax to test a new experimental coronavirus vaccine

Despite the encouraging news of potentially successful COVID-19 vaccine trials, there is not yet an FDA-approved vaccine available. Research into other effective coronavirus vaccines continues, including at UC Davis Health.

8 Dec 2020

FASLG gene may drive cytokine-linked adverse COVID-19 outcomes with age

A new study published on the preprint server bioRxiv in December 2020 reveals the role played by certain genetic factors in this group, in particular the FASLG gene belonging to the tumor necrosis factor (TNF) family.

8 Dec 2020

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

COVID-19 control measures reduce walking activities in United States

Study suggests vast majority of Seattle population remains susceptible to COVID-19

Different SARS-CoV-2 neutralization assays are reliable and concordant for antibody monitoring

The impact of COVID-19 on emergency medical services: a case study

Obesity increases the risk of severe COVID-19, study finds

Researchers develop analytical model to gauge SARS-CoV-2 transmission dynamics in schools

The effects of cigarette smoke and COPD on SARS-CoV-2 infection

UofL receives DoD funding to develop a nasal spray for preventing COVID-19

What safety measures have food suppliers implemented in response to COVID-19?

Neutrophils may play a key role in COVID-19-related thrombosis

Considerable COVID-19 vaccination hesitancy in UK may affect herd immunity, study finds

Predicting SARS-CoV-2 protein sequences

Developing antimicrobial products with resistance to coronavirus

Interim results show Oxford COVID-19 vaccine protects against symptomatic disease

Researchers compare data from blood donors to infer the attack rate of SARS-CoV-2 virus

Scientists determine key molecular processes used by coronavirus to infect human cells

Researchers assess the binding behavior of SARS-CoV-2 virus

Amilorides reduce SARS-CoV-2 viral replication in vitro

UC Davis Health joins with Novavax to test a new experimental coronavirus vaccine

FASLG gene may drive cytokine-linked adverse COVID-19 outcomes with age

Industry Focus eBook - Infectious Diseases (1st Edition) eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Industry Focus eBook - Infectious Diseases (1st Edition) eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in